AlphaFold predicted structure
TRPC5 · Q9UL62

Mean pLDDT
73.2/ 100
Confident
973 residues
Confidence breakdown
- Very high(≥ 90)37%
- Confident(70–90)32%
- Low(50–70)6%
- Very low(< 50)26%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
transient receptor potential cation channel subfamily C member 5
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Intellectual disability
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesSevere early-onset obesity
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)DDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesobesity due to melanocortin 4 receptor deficiency
obesity disorder
Obesity
Intellectual disability
breast carcinoma
breast cancer
colorectal carcinoma
autism
developmental and/or epileptic encephalopathy with spike-wave activation in sleep
Hypoglycemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Short transient receptor potential channel 5
Forms a receptor-activated non-selective calcium permeant cation channel (PubMed:16284075, PubMed:38959890, PubMed:37137991). Mediates calcium-dependent phosphatidylserine externalization and apoptosis in neurons via its association with PLSCR1 (By similarity). Acts on distinct neuronal populations in the hypothalamus to regulate innate behaviors including feeding, anxiety (flight/fight/fear), socialization, and maternal care (By similarity)
TRPC5 · Q9UL62

Mean pLDDT
73.2/ 100
Confident
973 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0